Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003291711> ?p ?o ?g. }
- W2003291711 endingPage "321" @default.
- W2003291711 startingPage "314" @default.
- W2003291711 abstract "In this review we give an overview of current knowledge of 68Ga-labeled pharmaceuticals, with focus on imaging receptor-mediated processes. A major advantage of a 68Ge/68Ga generator is its continuous source of 68Ga, independently from an on-site cyclotron. The increase in knowledge of purification and concentration of the eluate and the complex ligand chemistry has led to 68Ga-labeled pharmaceuticals with major clinical impact. 68Ga-labeled pharmaceuticals have the potential to cover all today's clinical options with 99mTc, with the concordant higher resolution of positron emission tomography (PET) in comparison with single photon emission computed tomography. 68Ga-labeled analogs of octreotide, such as DOTATOC, DOTANOC, and DOTA-TATE, are in clinical application in nuclear medicine, and these analogs are now the most frequently applied of all 68Ga-labeled pharmaceuticals. All the above-mentioned items in favor of successful application of 68Ga-labeled radiopharmaceuticals for imaging in patients are strong arguments for the development of a 68Ge/68Ga generator with Marketing Authorization and thus to provide pharmaceutical grade eluate. Moreover, now not one United States Food and Drug Administration–approved or European Medicines Agency–approved 68Ga-radiopharmaceutical is available. As soon as these are achieved, a whole new radiopharmacy providing PET radiopharmaceuticals might develop." @default.
- W2003291711 created "2016-06-24" @default.
- W2003291711 creator A5000332171 @default.
- W2003291711 creator A5007539874 @default.
- W2003291711 creator A5007991478 @default.
- W2003291711 creator A5011219611 @default.
- W2003291711 creator A5012997419 @default.
- W2003291711 creator A5065299486 @default.
- W2003291711 date "2011-07-01" @default.
- W2003291711 modified "2023-10-02" @default.
- W2003291711 title "68Ga-labeled DOTA-Peptides and 68Ga-labeled Radiopharmaceuticals for Positron Emission Tomography: Current Status of Research, Clinical Applications, and Future Perspectives" @default.
- W2003291711 cites W1480909434 @default.
- W2003291711 cites W1497075656 @default.
- W2003291711 cites W1584743295 @default.
- W2003291711 cites W1784656021 @default.
- W2003291711 cites W1952825395 @default.
- W2003291711 cites W1964170750 @default.
- W2003291711 cites W1970225047 @default.
- W2003291711 cites W1977700385 @default.
- W2003291711 cites W1979676849 @default.
- W2003291711 cites W1980658968 @default.
- W2003291711 cites W1980904855 @default.
- W2003291711 cites W1983667894 @default.
- W2003291711 cites W1984491578 @default.
- W2003291711 cites W1986293484 @default.
- W2003291711 cites W1986723218 @default.
- W2003291711 cites W1987319381 @default.
- W2003291711 cites W1996451950 @default.
- W2003291711 cites W2012655209 @default.
- W2003291711 cites W2012858026 @default.
- W2003291711 cites W2012965959 @default.
- W2003291711 cites W2019183165 @default.
- W2003291711 cites W2019496098 @default.
- W2003291711 cites W2025231466 @default.
- W2003291711 cites W2028354607 @default.
- W2003291711 cites W2028397320 @default.
- W2003291711 cites W2028850005 @default.
- W2003291711 cites W2031523213 @default.
- W2003291711 cites W2033533878 @default.
- W2003291711 cites W2035619243 @default.
- W2003291711 cites W2036402960 @default.
- W2003291711 cites W2039746367 @default.
- W2003291711 cites W2041003815 @default.
- W2003291711 cites W2041660853 @default.
- W2003291711 cites W2041958763 @default.
- W2003291711 cites W2042243326 @default.
- W2003291711 cites W2042686614 @default.
- W2003291711 cites W2042857160 @default.
- W2003291711 cites W2048765907 @default.
- W2003291711 cites W2051636198 @default.
- W2003291711 cites W2054703028 @default.
- W2003291711 cites W2059586804 @default.
- W2003291711 cites W2059777719 @default.
- W2003291711 cites W2060039676 @default.
- W2003291711 cites W2063493962 @default.
- W2003291711 cites W2065361341 @default.
- W2003291711 cites W2065428224 @default.
- W2003291711 cites W2068030704 @default.
- W2003291711 cites W2068695685 @default.
- W2003291711 cites W2072587957 @default.
- W2003291711 cites W2075075102 @default.
- W2003291711 cites W2076816135 @default.
- W2003291711 cites W2079633798 @default.
- W2003291711 cites W2080916065 @default.
- W2003291711 cites W2086383155 @default.
- W2003291711 cites W2102407781 @default.
- W2003291711 cites W2106680642 @default.
- W2003291711 cites W2111002001 @default.
- W2003291711 cites W2122196655 @default.
- W2003291711 cites W2123462156 @default.
- W2003291711 cites W2128006663 @default.
- W2003291711 cites W2128876754 @default.
- W2003291711 cites W2143921057 @default.
- W2003291711 cites W2160125502 @default.
- W2003291711 cites W2160463570 @default.
- W2003291711 cites W2161377113 @default.
- W2003291711 cites W2162735572 @default.
- W2003291711 cites W2338107399 @default.
- W2003291711 cites W51284586 @default.
- W2003291711 doi "https://doi.org/10.1053/j.semnuclmed.2011.02.001" @default.
- W2003291711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21624565" @default.
- W2003291711 hasPublicationYear "2011" @default.
- W2003291711 type Work @default.
- W2003291711 sameAs 2003291711 @default.
- W2003291711 citedByCount "171" @default.
- W2003291711 countsByYear W20032917112012 @default.
- W2003291711 countsByYear W20032917112013 @default.
- W2003291711 countsByYear W20032917112014 @default.
- W2003291711 countsByYear W20032917112015 @default.
- W2003291711 countsByYear W20032917112016 @default.
- W2003291711 countsByYear W20032917112017 @default.
- W2003291711 countsByYear W20032917112018 @default.
- W2003291711 countsByYear W20032917112019 @default.
- W2003291711 countsByYear W20032917112020 @default.
- W2003291711 countsByYear W20032917112021 @default.
- W2003291711 countsByYear W20032917112022 @default.
- W2003291711 countsByYear W20032917112023 @default.
- W2003291711 crossrefType "journal-article" @default.